• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    3M Provides Medium-Term Financial Outlook at 2025 Investor Day; Presents Strategic Priorities that Will Drive Growth, Operational Excellence, and Return Cash to Shareholders

    2/26/25 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    • Highlights innovation and commercial excellence initiatives that will accelerate sales growth to outperform macro
    • Outlines operational excellence strategies to drive margin expansion, earnings growth, and strong free cash flow
    • Provides balanced capital deployment framework focused on investing in the business and returning at least $10 billion in cash to shareholders over the outlook period

    ST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- 3M (NYSE:MMM) will host its 2025 Investor Day today in St. Paul, Minnesota, beginning at 8 a.m. CST. During the event, 3M will provide its medium-term financial outlook, and leadership will discuss priorities that will deliver sustainable value creation.

    "3M is an iconic company with an unmatched spirit of innovation," said William Brown, 3M Chief Executive Officer. "Today we are reiterating our 2025 guidance and sharing our medium-term outlook, which builds upon our foundational strengths and provides a clear path to reinvigorate top line growth and drive operational performance. I am confident that our new performance-based culture and 3M eXcellence operating system allow us to capitalize on opportunities to deliver value for customers and shareholders."

    Medium-Term Financial Outlook

    3M reiterates its 2025 guidance and provides the following 2026 and 2027 adjusted outlook:

    • Organic sales growth that will outperform macro.



    • Operating margin of ~25% by 2027.



    • High-single digit EPS growth annually.



    • Greater than 100% free cash flow conversion. 

    Conference Call

    Today's meeting will be webcast live beginning at 8:00 a.m. CST and is scheduled to end at noon CST. Investors can access this meeting via the following:

    • Live webcast at https://investors.3M.com



    • Webcast replay at https://investors.3m.com/news-events/events-presentations 

    Presentation materials will be available on the Investor Relations website at the start of the event.

    Supplemental Financial Information Non-GAAP Measures

    View the Supplemental Financial Information on 3M's website: https://investors.3m.com/

    Forward-Looking Statements

    This news release contains forward-looking statements. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast," "future," "outlook," "guidance" and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; trade restrictions such as sanctions, tariffs, and retaliatory measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals known as "PFAS," including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement to resolve claims by public water suppliers in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws, or regulations; (15) matters relating to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; the risk that any consents or approvals required will not be obtained; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs ("CAE") and related products, including those related to the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates and/or 3M. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

    About 3M

    3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news.

    Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's news center and the social media channels such as @3M or @3MNews.

    3M Contacts

    Investor Contacts:

    Diane Farrow, 612-202-2449

    or

    Eric Herron, 651-233-0043

    Media Contact:

    Sean Lynch, [email protected]

    3M (PRNewsfoto/3M)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-provides-medium-term-financial-outlook-at-2025-investor-day-presents-strategic-priorities-that-will-drive-growth-operational-excellence-and-return-cash-to-shareholders-302385508.html

    SOURCE 3M Company

    Get the next $MMM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • 3M upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded 3M from Equal Weight to Overweight and set a new price target of $170.00 from $140.00 previously

      1/22/25 7:45:34 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by UBS with a new price target

      UBS upgraded 3M from Neutral to Buy and set a new price target of $184.00

      11/13/24 8:05:47 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by Melius

      Melius upgraded 3M from Hold to Buy

      10/22/24 11:24:35 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Financials

    Live finance-specific insights

    See more
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., Apr. 8, 2025 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event: First-quarter 2025 earnings conference call on Tuesday, Apr. 22, 2025, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news. Investor Contact:Diane Farrow

      4/8/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Provides Medium-Term Financial Outlook at 2025 Investor Day; Presents Strategic Priorities that Will Drive Growth, Operational Excellence, and Return Cash to Shareholders

      Highlights innovation and commercial excellence initiatives that will accelerate sales growth to outperform macroOutlines operational excellence strategies to drive margin expansion, earnings growth, and strong free cash flowProvides balanced capital deployment framework focused on investing in the business and returning at least $10 billion in cash to shareholders over the outlook periodST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- 3M (NYSE:MMM) will host its 2025 Investor Day today in St. Paul, Minnesota, beginning at 8 a.m. CST. During the event, 3M will provide its medium-term financial outlook, and leadership will discuss priorities that will deliver sustainable value creation. "3M is

      2/26/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., April 30, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event: BofA Securities Industrials, Transportation & Airlines Key Leaders Conference on Wednesday, May 14, 2025. William Brown, Chairman and Chief Executive Officer will speak at 8:45 a.m. ET.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn

      4/30/25 10:10:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • FUTURO Brand just got an upgrade with movement in mind

      Relieve muscle and joint stiffness, soreness and swelling with our new compression sleeves that deliver comfortable wear all day long. ST. PAUL, Minn., April 16, 2025 /PRNewswire/ -- FUTURO™ Brand introduces a collection of redesigned premium compression sleeves for muscle and joint support. The new sleek look, smooth low-profile construction and ultra-soft fabric with four-way stretch delivers an unrestricted, comfortable fit, flexibility and range of motion. Prioritizing all day comfort and wear, a no-cutout construction helps reduce chafing and rubbing and an innovative comfort band with silicone beading helps prevent slipping and rolling. The reengineered compression sleeves, supported b

      4/16/25 12:13:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

      For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

      1/22/21 3:54:10 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    SEC Filings

    See more
    • SEC Form 10-Q filed by 3M Company

      10-Q - 3M CO (0000066740) (Filer)

      4/22/25 12:24:49 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - 3M CO (0000066740) (Filer)

      4/22/25 6:36:10 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by 3M Company

      DEFA14A - 3M CO (0000066740) (Filer)

      3/28/25 4:02:11 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Pilz Torsten

      3 - 3M CO (0000066740) (Issuer)

      5/7/25 12:29:26 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Sr Vice President & CAO Reinseth Theresa E covered exercise/tax liability with 441 shares and exercised 1,441 shares at a strike of $142.08, increasing direct ownership by 20% to 6,008 units (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:35:54 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Chairman & CEO Brown William M exercised 8,577 shares at a strike of $142.08 and covered exercise/tax liability with 3,912 shares (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:24:22 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/13/24 4:56:03 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/23 10:54:46 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/22 3:15:56 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    See more
    • 3M Announces New Board Appointments

      William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

      2/10/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M joins consortium to accelerate semiconductor technology in the US

      ST. PAUL, Minn., Feb. 3, 2025  /PRNewswire/ -- 3M is expanding its commitment to the semiconductor industry by joining the US-JOINT Consortium, a strategic partnership of 12 leading semiconductor suppliers. The consortium drives research and development in next-generation semiconductor advanced packaging and back-end processing technologies anchored by a new cutting-edge facility in Silicon Valley. "As the demands of AI and other high performance computing technologies increase, suppliers must work together to provide comprehensive solutions to tough challenges on increasingly

      2/3/25 10:55:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M's "Green Works" docuseries spotlights how green jobs can help drive a more sustainable future

      3M's docuseries debuts at Fast Company Innovation Festival ahead of New York Climate WeekCollaboration with Work on Climate will address the critical need for more green talent and provide resources for professionals3M to emphasize importance of inspiring the workforce, closing the skills gap and developing a green economy talent pipeline during New York Climate Week eventsST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- 3M is premiering a new global docuseries today, "Green Works," to spotlight individuals working to address climate challenges and the critical need for more talent to support the green transition. The film, produced by 3M in partnership with Generous Films, features five indi

      9/18/24 3:00:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care